Newbridge Financial Services Group’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-175
Closed -$3.8K 1244
2025
Q4
$3.8K Buy
+175
New +$3.45K ﹤0.01% 940

Other funds holding ROIV

Newbridge Financial Services Group's ROIV Position: Q1 2026 in Review

Newbridge Financial Services Group sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 175 shares — an estimated $3.8K sold.

Newbridge Financial Services Group first reported a position in ROIV in Q4 2025 and held it in 1 quarter. The position peaked at $3.8K in Q4 2025. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Newbridge Financial Services Group reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
  • Newbridge Financial Services Group sold 175 Roivant Sciences shares in Q1 2026, an estimated $3.8K.
  • Newbridge Financial Services Group first reported a position in Roivant Sciences in Q4 2025 and held it in 1 quarter.
  • Newbridge Financial Services Group's Roivant Sciences position peaked at $3.8K in Q4 2025.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.